Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD

NAUnknownINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

June 30, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

ICS withdrawal

Bronchodilator therapy is optimized according to the latest COPD guideline of the Dutch College of General Practitioners (NHG) and inhaled corticosteroids are withdrawn.

OTHER

Usual care

Bronchodilator therapy is optimized according to the latest COPD guideline of the Dutch College of General Practitioners (NHG)

Trial Locations (1)

6500 HB

RECRUITING

Radboud University Medical Centre, Department of Primary and Community Care, Nijmegen

Sponsors
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Radboud University Medical Center

OTHER